Get to know our clinical trials

Clinical trial of ursodeoxycholic acid vs. placebo for the prevention of recurrent acute biliary pAncreatitis.

THE OBJECTIVE OF THE PROJECT IS TO EVALUATE THE FREQUENCY OF PROBLEMS DERIVED FROM THE PRESENCE OF GALLSTONES IN PATIENTS CONSUMING URSODEOXYCHOLIC ACID VERSUS PATIENTS CONSUMING PLACEBO (CAPSULES WITH THE SAME APPEARANCE AS THOSE CONTAINING URSODEOXYCHOLIC ACID BUT NOT CONTAINING THIS DRUG).

Imagen de la Dra. Critina Carretero Ribón, especialista en Digestivo de la Clínica Universidad de Navarra. La Dra. Carretero se dedica preferencialmente a los tumores digestivos y a la endoscopia.
Dr. Cristina Carretero Ribón [SP] Curriculum
Specialist Digestive Department
Navarre headquarters
Status
In recruitment
headquarters
Pamplona/Madrid

Technical Summary

  • URSODEOXYCHOLIC ACID VS. PLACEBO FOR THE PREVENTION OF RECURRENT ACUTE BILIARY PANCREATITIS. RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL.
  • Code EudraCT: 2020-005901-16
  • Protocol number: OSOPOLAR
  • Promoter: Enrique Madeira

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

More information about this clinical trial

Information offered by the Spanish Registry of Clinical Studies

  • Summary
  • Information
  • Calendar
  • Headquarters
  • Drugs
Read more about this clinical trial
Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial

I want to make an appointment
Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.

I WANT TO REQUEST A SECOND OPINION